FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:THRA-PSMD3

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: THRA-PSMD3
FusionPDB ID: 90736
FusionGDB2.0 ID: 90736
HgeneTgene
Gene symbol

THRA

PSMD3

Gene ID

7067

5709

Gene namethyroid hormone receptor alphaproteasome 26S subunit, non-ATPase 3
SynonymsAR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1P58|RPN3|S3|TSTA2
Cytomap

17q21.1

17q21.1

Type of geneprotein-codingprotein-coding
Descriptionthyroid hormone receptor alphaEAR-7ERBA-related 7V-erbA-related protein 7c-erbA-alphanuclear receptor subfamily 1 group A member 1thyroid hormone receptor alpha 1thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homo26S proteasome non-ATPase regulatory subunit 326S proteasome regulatory subunit RPN326S proteasome regulatory subunit S3proteasome (prosome, macropain) 26S subunit, non-ATPase, 3proteasome subunit p58tissue specific transplantation antigen 2
Modification date2020031320200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000264637, ENST00000394121, 
ENST00000450525, ENST00000546243, 
ENST00000584985, 
ENST00000541736, 
ENST00000264639, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score14 X 10 X 10=140016 X 18 X 8=2304
# samples 2321
** MAII scorelog2(23/1400*10)=-2.60572106088795
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(21/2304*10)=-3.45567948377619
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: THRA [Title/Abstract] AND PSMD3 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: THRA [Title/Abstract] AND PSMD3 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)THRA(38245586)-PSMD3(38140547), # samples:3
THRA(38241068)-PSMD3(38142828), # samples:3
Anticipated loss of major functional domain due to fusion event.THRA-PSMD3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
THRA-PSMD3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
THRA-PSMD3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
THRA-PSMD3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
THRA-PSMD3 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
THRA-PSMD3 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF.
THRA-PSMD3 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF.
THRA-PSMD3 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
THRA-PSMD3 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneTHRA

GO:0006357

regulation of transcription by RNA polymerase II

18052923

HgeneTHRA

GO:0006366

transcription by RNA polymerase II

8710870|9653119

HgeneTHRA

GO:0009755

hormone-mediated signaling pathway

18052923

HgeneTHRA

GO:0017055

negative regulation of RNA polymerase II transcriptional preinitiation complex assembly

8524305

HgeneTHRA

GO:0045892

negative regulation of transcription, DNA-templated

8710870

HgeneTHRA

GO:2000143

negative regulation of DNA-templated transcription, initiation

8524305



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:38245586/chr17:38140547)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across THRA (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across PSMD3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000546243THRAchr1738245586+ENST00000264639PSMD3chr1738140547+3545178115703165531

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000546243ENST00000264639THRAchr1738245586+PSMD3chr1738140547+0.0038999870.99609995

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for THRA-PSMD3

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
THRAchr1738245586PSMD3chr1738140547178169GGAVSCSSQDPILSDIKEHVKQLEKA

Top

Potential FusionNeoAntigen Information of THRA-PSMD3 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
THRA-PSMD3_38245586_38140547.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:67ILSDIKEHV0.99920.62911120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:13ILSDIKEHV0.99920.60751120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:27ILSDIKEHV0.99920.52571120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:24ILSDIKEHV0.99920.62911120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:30ILSDIKEHV0.99920.62911120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:60ILSDIKEHV0.99920.59361120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:11ILSDIKEHV0.99920.66281120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:21ILSDIKEHV0.99910.73611120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:16ILSDIKEHV0.99850.5581120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:35ILSDIKEHV0.99590.67091120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:38ILSDIKEHV0.99540.50541120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:04ILSDIKEHV0.99410.61551120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:29ILSDIKEHV0.98970.63541120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:20ILSDIKEHV0.97960.63981120
THRA-PSMD3chr1738245586chr17381405471781HLA-B13:01SQDPILSDI0.5910.7898716
THRA-PSMD3chr1738245586chr17381405471781HLA-B38:01SQDPILSDI0.54610.8537716
THRA-PSMD3chr1738245586chr17381405471781HLA-B39:13SQDPILSDI0.51230.7214716
THRA-PSMD3chr1738245586chr17381405471781HLA-B13:02ILSDIKEHV0.20220.60881120
THRA-PSMD3chr1738245586chr17381405471781HLA-B52:01SQDPILSDI0.09440.8586716
THRA-PSMD3chr1738245586chr17381405471781HLA-C05:09LSDIKEHV10.87011220
THRA-PSMD3chr1738245586chr17381405471781HLA-C08:15LSDIKEHV10.89731220
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:07ILSDIKEHV0.99920.64791120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:01ILSDIKEHV0.99920.62911120
THRA-PSMD3chr1738245586chr17381405471781HLA-C05:09SQDPILSDI0.99880.8414716
THRA-PSMD3chr1738245586chr17381405471781HLA-C04:07SQDPILSDI0.99820.7491716
THRA-PSMD3chr1738245586chr17381405471781HLA-C08:15SQDPILSDI0.9960.913716
THRA-PSMD3chr1738245586chr17381405471781HLA-C04:06SQDPILSDI0.96850.7964716
THRA-PSMD3chr1738245586chr17381405471781HLA-B39:08SQDPILSDI0.55820.7716
THRA-PSMD3chr1738245586chr17381405471781HLA-C08:02LSDIKEHV10.89731220
THRA-PSMD3chr1738245586chr17381405471781HLA-C05:01LSDIKEHV10.87011220
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:03ILSDIKEHV0.99970.64371120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:06ILSDIKEHV0.99910.73611120
THRA-PSMD3chr1738245586chr17381405471781HLA-A02:14ILSDIKEHV0.99910.63191120
THRA-PSMD3chr1738245586chr17381405471781HLA-C05:01SQDPILSDI0.99880.8414716
THRA-PSMD3chr1738245586chr17381405471781HLA-C04:03SQDPILSDI0.99870.794716
THRA-PSMD3chr1738245586chr17381405471781HLA-C04:01SQDPILSDI0.99820.7491716
THRA-PSMD3chr1738245586chr17381405471781HLA-C18:01SQDPILSDI0.99760.7509716
THRA-PSMD3chr1738245586chr17381405471781HLA-C08:02SQDPILSDI0.9960.913716
THRA-PSMD3chr1738245586chr17381405471781HLA-B39:02SQDPILSDI0.56940.7291716
THRA-PSMD3chr1738245586chr17381405471781HLA-B38:05SQDPILSDI0.54610.8537716
THRA-PSMD3chr1738245586chr17381405471781HLA-B39:11SQDPILSDI0.47250.5964716
THRA-PSMD3chr1738245586chr17381405471781HLA-C07:04ILSDIKEHV0.06170.89321120
THRA-PSMD3chr1738245586chr17381405471781HLA-A30:01SSQDPILSDIK0.98870.6452617

Top

Potential FusionNeoAntigen Information of THRA-PSMD3 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
THRA-PSMD3_38245586_38140547.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
THRA-PSMD3chr1738245586chr17381405471781DRB1-0301SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0301QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0301SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0301DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0303SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0303QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0303SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0303DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0305SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0305QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0305SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0305DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0307SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0307QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0307SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0307DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0310SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0310QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0310SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0310DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0310CSSQDPILSDIKEHV520
THRA-PSMD3chr1738245586chr17381405471781DRB1-0313SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0313QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0313SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0313DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0315SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0315QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0315SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0315DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0318SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0318QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0318SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0318DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0320SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0320QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0320SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0320DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0322SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0322QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0322SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0322DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0324SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0324QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0324SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0324DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0326SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0326QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0326SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0326DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0326CSSQDPILSDIKEHV520
THRA-PSMD3chr1738245586chr17381405471781DRB1-0328SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0328QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0328SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0328DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0330SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0330QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0330SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0330DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0332SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0332QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0332SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0332DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0334SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0334QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0334SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0334DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0336SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0336QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0336SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0336DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0338SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0338QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0338SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0340SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0340QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0340SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0340DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0342SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0342QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0342SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0342DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0344SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0344QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0344SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0344DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0346SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0346QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0346SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0346DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0348SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0348QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0348SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0348DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0350SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0350QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0350SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0350DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0352SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0352QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0352SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0352DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0354SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0354QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-0354SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-0354DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-0466SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-0466QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1102ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1107SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1107QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1107SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1107DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-1116ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1117SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1117QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1121ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1134SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1136ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1148ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1152SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1152QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1153SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1153QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1165ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1170ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1179SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1179QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1179SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1301ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1304ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1304PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1308ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-13101SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1310SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1319ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1320ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1322ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1327ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1331SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1332ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1332PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1333SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1333QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1333SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1335ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1337SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1338ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1338PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1341SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1343ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1343PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1344SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1348ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1348PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1351ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1352ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1353ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1354ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1359ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1361ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1364ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1365ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1365PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1368ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1369ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1370ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1371ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1372ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1375ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1375PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1376ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1376PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1378ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1379ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1380ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1381SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1381QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1381SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1383ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1384ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1387ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1389SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1389QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1391ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1392ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1393ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1393PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1394SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1394QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1394SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1394DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-1398ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1401SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1401QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1402SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1404SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1404QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1405SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1405QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1406SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1406QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1407SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1408SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1408QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1409SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1409QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1411SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1413SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1416ILSDIKEHVKQLEKA1126
THRA-PSMD3chr1738245586chr17381405471781DRB1-1416PILSDIKEHVKQLEK1025
THRA-PSMD3chr1738245586chr17381405471781DRB1-1416SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1416QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1417SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1418SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1418QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1419SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1419QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1419SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1420SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1420QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1421SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1421QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1421SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1421DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-1423SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1423QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1424SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1426SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1426QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1428SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1429SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1429QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1431SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1431QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1432SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1432QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1432SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1433SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1433QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1434SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1434QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1435SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1435QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1437SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1437QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1438SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1438QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1438SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1438DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-1439SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1441SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1443SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1443QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1445SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1445QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1447SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1447QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1448SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1449SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1449QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1449SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1450SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1450QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1450SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1454SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1454QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1455SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1455QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1456SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1456QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1458SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1458QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1459SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1459QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1460SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1460QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1461SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1461QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1462SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1462QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1462SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1464SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1465SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1465QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1470SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1470QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1470SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1471SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1471QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1472SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1474SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1475SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1475QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1475SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1476SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1476QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1476SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1476DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-1476CSSQDPILSDIKEHV520
THRA-PSMD3chr1738245586chr17381405471781DRB1-1479SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1479QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1479SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1479DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-1479CSSQDPILSDIKEHV520
THRA-PSMD3chr1738245586chr17381405471781DRB1-1480SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1480QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1480SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1481SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1481QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1482SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1482QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1482SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1482DPILSDIKEHVKQLE924
THRA-PSMD3chr1738245586chr17381405471781DRB1-1483SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1483QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1486SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1486QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1487SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1487QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1488SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1488QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1490SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1490QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1491SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1491QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1493SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1493QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1493SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1494SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1495SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1495QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1495SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB1-1496SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1496QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1497SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1497QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1499SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB1-1499QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB1-1499SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB3-0114SQDPILSDIKEHVKQ722
THRA-PSMD3chr1738245586chr17381405471781DRB3-0114QDPILSDIKEHVKQL823
THRA-PSMD3chr1738245586chr17381405471781DRB3-0114SSQDPILSDIKEHVK621
THRA-PSMD3chr1738245586chr17381405471781DRB3-0114DPILSDIKEHVKQLE924

Top

Fusion breakpoint peptide structures of THRA-PSMD3

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
9041SSQDPILSDIKEHVTHRAPSMD3chr1738245586chr17381405471781

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of THRA-PSMD3

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN9041SSQDPILSDIKEHV-7.75776-7.86956
HLA-B14:023BVN9041SSQDPILSDIKEHV-4.52646-5.56956
HLA-B52:013W399041SSQDPILSDIKEHV-7.1873-7.2991
HLA-B52:013W399041SSQDPILSDIKEHV-2.81174-3.85484
HLA-A11:014UQ29041SSQDPILSDIKEHV-5.13576-5.24756
HLA-A24:025HGA9041SSQDPILSDIKEHV-8.42076-8.53256
HLA-A24:025HGA9041SSQDPILSDIKEHV-7.10496-8.14806
HLA-B27:056PYJ9041SSQDPILSDIKEHV-9.28296-9.39476
HLA-B44:053DX89041SSQDPILSDIKEHV-6.88262-6.99442
HLA-B44:053DX89041SSQDPILSDIKEHV-5.46822-6.51132

Top

Vaccine Design for the FusionNeoAntigens of THRA-PSMD3

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
THRA-PSMD3chr1738245586chr17381405471120ILSDIKEHVTCTCAGACATCAAGGAGCACGTGAAAC
THRA-PSMD3chr1738245586chr17381405471220LSDIKEHVCAGACATCAAGGAGCACGTGAAAC
THRA-PSMD3chr1738245586chr1738140547617SSQDPILSDIKCCCAGGACCCCATCCTCTCAGACATCAAGGAGC
THRA-PSMD3chr1738245586chr1738140547716SQDPILSDIAGGACCCCATCCTCTCAGACATCAAGG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
THRA-PSMD3chr1738245586chr17381405471025PILSDIKEHVKQLEKTCCTCTCAGACATCAAGGAGCACGTGAAACAGCTAGAGAAAGCGG
THRA-PSMD3chr1738245586chr17381405471126ILSDIKEHVKQLEKATCTCAGACATCAAGGAGCACGTGAAACAGCTAGAGAAAGCGGTTT
THRA-PSMD3chr1738245586chr1738140547520CSSQDPILSDIKEHVGTTCCCAGGACCCCATCCTCTCAGACATCAAGGAGCACGTGAAAC
THRA-PSMD3chr1738245586chr1738140547621SSQDPILSDIKEHVKCCCAGGACCCCATCCTCTCAGACATCAAGGAGCACGTGAAACAGC
THRA-PSMD3chr1738245586chr1738140547722SQDPILSDIKEHVKQAGGACCCCATCCTCTCAGACATCAAGGAGCACGTGAAACAGCTAG
THRA-PSMD3chr1738245586chr1738140547823QDPILSDIKEHVKQLACCCCATCCTCTCAGACATCAAGGAGCACGTGAAACAGCTAGAGA
THRA-PSMD3chr1738245586chr1738140547924DPILSDIKEHVKQLECCATCCTCTCAGACATCAAGGAGCACGTGAAACAGCTAGAGAAAG

Top

Information of the samples that have these potential fusion neoantigens of THRA-PSMD3

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LUADTHRA-PSMD3chr1738245586ENST00000546243chr1738140547ENST00000264639TCGA-95-7043-01A

Top

Potential target of CAR-T therapy development for THRA-PSMD3

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to THRA-PSMD3

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to THRA-PSMD3

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource